77 results on '"Dores, Graça M."'
Search Results
2. Patterns of red blood cell utilization: Harnessing electronic health records data from the Information Standard for Blood and Transplant (ISBT) 128 system within the Biologics Effectiveness and Safety (BEST) initiative
3. Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
4. Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018
5. Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion
6. Immune globulin usage trends in commercially insured and Medicare populations, 2009–2019
7. Leukemias
8. U.S. Food and Drug Administration Analysis of Newly Identified Adverse Events With Lurbinectedin: Extravasation, Rhabdomyolysis, and Tumor Lysis Syndrome
9. Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia
10. Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration
11. Association of Daratumumab Use With Ocular Events in a Case Series of US Adults
12. Uncovering the Genetic Etiology of the (Posttherapy) Broken Heart
13. Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults
14. Benzene exposure and risk of benzene poisoning in Chinese workers
15. Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System
16. Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015–2018
17. Cause‐specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001–2017
18. Acute myocardial infarction: Development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database
19. Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel
20. The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma
21. Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
22. Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016
23. Epidemiology and Hereditary Aspects of Acute Leukemia
24. Safety Surveillance of Bivalent Meningococcal Group B Vaccine, Vaccine Adverse Event Reporting System, 2014–2018
25. Benzene exposure‐response and risk of lymphoid neoplasms in Chinese workers: A multicenter case‐cohort study
26. Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data
27. Cause‐specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000–2016
28. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017
29. Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010–December 2018
30. Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System
31. Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
32. Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study
33. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes
34. Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016–June 2018
35. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era
36. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014
37. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival
38. Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects
39. Increased pancreatic cancer risk following radiotherapy for testicular cancer
40. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12
41. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma
42. A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992–2010
43. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site
44. Stomach Cancer Risk After Treatment for Hodgkin Lymphoma
45. Radiation Dose and Subsequent Risk for Stomach Cancer in Long-term Survivors of Cervical Cancer
46. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008
47. Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007
48. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
49. Melanoma of the skin and laterality
50. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.